2023 annual financial data
Atrium Therapeutics 2023 Operating margin
Direct answer
Operating margin was -2,464.41%.
Operating income was -235,598,000 USD and net income was -212,220,000 USD.
Operating cash flow was -119,064,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,560,000 USD
- Operating income
- -235,598,000 USD
- Net income
- -212,220,000 USD
- Operating cash flow
- -119,064,000 USD